2020 Q2 Form 10-Q Financial Statement

#000162828020009439 Filed on June 15, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2
Revenue $77.29M $130.3M
YoY Change -40.69% 5.39%
Cost Of Revenue $75.70M $94.62M
YoY Change -20.0% 6.72%
Gross Profit $1.594M $35.68M
YoY Change -95.53% 2.02%
Gross Profit Margin 2.06% 27.39%
Selling, General & Admin $30.00M $35.54M
YoY Change -15.6% 5.62%
% of Gross Profit 1881.74% 99.59%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $5.020M $5.210M
YoY Change -3.65% -10.48%
% of Gross Profit 314.93% 14.6%
Operating Expenses $30.00M $35.54M
YoY Change -15.6% 5.62%
Operating Profit -$28.40M $146.0K
YoY Change -19552.74% -89.03%
Interest Expense $300.0K
YoY Change
% of Operating Profit
Other Income/Expense, Net $409.0K $829.0K
YoY Change -50.66% 116.45%
Pretax Income -$27.99M $975.0K
YoY Change -2970.97% -43.12%
Income Tax -$10.60M $300.0K
% Of Pretax Income 30.77%
Net Earnings -$17.40M $677.0K
YoY Change -2669.42% -44.64%
Net Earnings / Revenue -22.51% 0.52%
Basic Earnings Per Share -$0.59 $0.02
Diluted Earnings Per Share -$0.59 $0.02
COMMON SHARES
Basic Shares Outstanding 29.68M shares 29.47M shares
Diluted Shares Outstanding 29.68M shares 29.81M shares

Balance Sheet

Concept 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $110.8M $109.6M
YoY Change 1.13% 4.55%
Cash & Equivalents $65.13M $33.86M
Short-Term Investments $45.71M $75.74M
Other Short-Term Assets $2.100M $5.300M
YoY Change -60.38% -43.01%
Inventory $67.65M $58.96M
Prepaid Expenses
Receivables $13.40M $6.300M
Other Receivables $0.00 $0.00
Total Short-Term Assets $194.3M $180.4M
YoY Change 7.72% 2.45%
LONG-TERM ASSETS
Property, Plant & Equipment $61.94M $70.61M
YoY Change -12.27% -12.33%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $7.422M $2.176M
YoY Change 241.08% -33.6%
Total Long-Term Assets $321.9M $316.9M
YoY Change 1.58% 278.1%
TOTAL ASSETS
Total Short-Term Assets $194.3M $180.4M
Total Long-Term Assets $321.9M $316.9M
Total Assets $516.2M $497.3M
YoY Change 3.8% 91.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $24.84M $23.48M
YoY Change 5.78% 20.38%
Accrued Expenses $13.59M $17.04M
YoY Change -20.26% -28.12%
Deferred Revenue $2.600M $1.700M
YoY Change 52.94%
Short-Term Debt $23.70M $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $143.5M $109.2M
YoY Change 31.37% 74.03%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $558.0K $1.422M
YoY Change -60.76% -42.57%
Total Long-Term Liabilities $558.0K $1.422M
YoY Change -60.76% -42.57%
TOTAL LIABILITIES
Total Short-Term Liabilities $143.5M $109.2M
Total Long-Term Liabilities $558.0K $1.422M
Total Liabilities $373.2M $332.8M
YoY Change 12.15% 246.23%
SHAREHOLDERS EQUITY
Retained Earnings -$11.12M $14.01M
YoY Change -179.32% -26.52%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $143.0M $164.5M
YoY Change
Total Liabilities & Shareholders Equity $516.2M $497.3M
YoY Change 3.8% 91.36%

Cashflow Statement

Concept 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income -$17.40M $677.0K
YoY Change -2669.42% -44.64%
Depreciation, Depletion And Amortization $5.020M $5.210M
YoY Change -3.65% -10.48%
Cash From Operating Activities -$19.57M -$2.278M
YoY Change 758.91% -440.0%
INVESTING ACTIVITIES
Capital Expenditures $3.548M $3.059M
YoY Change 15.99% 3.84%
Acquisitions
YoY Change
Other Investing Activities $24.11M $430.0K
YoY Change 5506.98% -97.78%
Cash From Investing Activities $20.56M -$2.631M
YoY Change -881.6% -116.04%
FINANCING ACTIVITIES
Cash Dividend Paid $29.68M $29.45M
YoY Change 0.76% 1.33%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$6.002M -$29.39M
YoY Change -79.58% 1.06%
NET CHANGE
Cash From Operating Activities -$19.57M -$2.278M
Cash From Investing Activities $20.56M -$2.631M
Cash From Financing Activities -$6.002M -$29.39M
Net Change In Cash -$5.004M -$34.30M
YoY Change -85.41% 185.56%
FREE CASH FLOW
Cash From Operating Activities -$19.57M -$2.278M
Capital Expenditures $3.548M $3.059M
Free Cash Flow -$23.11M -$5.337M
YoY Change 333.09% 134.49%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q2 tlys Impaired Long Lived Assets Heldand Used Fair Value
ImpairedLongLivedAssetsHeldandUsedFairValue
203000 USD
CY2019Q2 tlys Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
-715000 USD
CY2020Q2 tlys Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
9741000 USD
CY2020Q2 tlys Leverage Ratio On Credit Facility
LeverageRatioOnCreditFacility
4.7
CY2019Q2 tlys Marketable Securities Accumulated Gross Unrealized Gain
MarketableSecuritiesAccumulatedGrossUnrealizedGain
215000 USD
CY2020Q1 tlys Marketable Securities Accumulated Gross Unrealized Gain
MarketableSecuritiesAccumulatedGrossUnrealizedGain
293000 USD
CY2020Q2 tlys Marketable Securities Accumulated Gross Unrealized Gain
MarketableSecuritiesAccumulatedGrossUnrealizedGain
275000 USD
CY2020Q2 tlys Number Of States
NumberOfStates
33 State
CY2020Q2 tlys Numberof Pop Up Stores
NumberofPopUpStores
1 store
CY2019Q2 tlys Numberof Stores Testedfor Impairment
NumberofStoresTestedforImpairment
3 store
CY2020Q2 tlys Numberof Stores Testedfor Impairment
NumberofStoresTestedforImpairment
12 store
CY2019Q2 tlys Numberof Storeswith Impairment
NumberofStoreswithImpairment
0 store
CY2020Q2 tlys Numberof Storeswith Impairment
NumberofStoreswithImpairment
5 store
CY2020Q2 tlys Percentage Of Awards Vesting On Grant Date
PercentageOfAwardsVestingOnGrantDate
0.25
CY2019Q2 tlys Percentage Of Total Net Sales
PercentageOfTotalNetSales
1.00
CY2020Q2 tlys Percentage Of Total Net Sales
PercentageOfTotalNetSales
1.00
CY2019Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
23479000 USD
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
20562000 USD
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
24837000 USD
CY2019Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
17044000 USD
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20755000 USD
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13591000 USD
CY2019Q2 us-gaap Accrued Liabilities For Unredeeemed Gift Cards
AccruedLiabilitiesForUnredeeemedGiftCards
7400000 USD
CY2020Q1 us-gaap Accrued Liabilities For Unredeeemed Gift Cards
AccruedLiabilitiesForUnredeeemedGiftCards
9300000 USD
CY2020Q2 us-gaap Accrued Liabilities For Unredeeemed Gift Cards
AccruedLiabilitiesForUnredeeemedGiftCards
8100000 USD
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
157000 USD
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
214000 USD
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
201000 USD
CY2019Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
150331000 USD
CY2020Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
153377000 USD
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
153878000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Income Tax Deficiency From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalIncomeTaxDeficiencyFromShareBasedCompensation
85000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
529000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
501000 USD
CY2019Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2020Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
333000 USD
CY2019Q2 us-gaap Assets
Assets
497285000 USD
CY2020Q1 us-gaap Assets
Assets
546640000 USD
CY2020Q2 us-gaap Assets
Assets
516194000 USD
CY2019Q2 us-gaap Assets Current
AssetsCurrent
180362000 USD
CY2020Q1 us-gaap Assets Current
AssetsCurrent
208864000 USD
CY2020Q2 us-gaap Assets Current
AssetsCurrent
194277000 USD
CY2019Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 USD
CY2020Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2066000 USD
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33864000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
70137000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
65133000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
68160000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33864000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
70137000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
65133000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-34296000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5004000 USD
CY2019Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
608000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17408000 USD
CY2019Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1700000 USD
CY2020Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2400000 USD
CY2020Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2600000 USD
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
94619000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
75695000 USD
CY2020Q2 dei Amendment Flag
AmendmentFlag
false
CY2020Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--02-01
CY2020Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q2 dei Document Period End Date
DocumentPeriodEndDate
2020-05-02
CY2020Q2 dei Document Type
DocumentType
10-Q
CY2020Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001524025
CY2020Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q2 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2020Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q2 dei Entity Registrant Name
EntityRegistrantName
TILLY'S, INC.
CY2020Q2 dei Entity Shell Company
EntityShellCompany
false
CY2020Q2 dei Entity Small Business
EntitySmallBusiness
true
CY2020Q2 tlys Customer Loyalty Program Expiration Period Of Partial Points
CustomerLoyaltyProgramExpirationPeriodOfPartialPoints
P365D
CY2020Q2 tlys Debt Instrument Covenant Minimum Eligible Inventory
DebtInstrumentCovenantMinimumEligibleInventory
50000000 USD
CY2020Q2 tlys Fixed Charge Coverage Ratio
FixedChargeCoverageRatio
0.8
CY2020Q2 tlys Impaired Long Lived Assets Heldand Used Carrying Amount
ImpairedLongLivedAssetsHeldandUsedCarryingAmount
536000 USD
CY2019Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1268000 USD
CY2020Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1042000 USD
CY2019Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1911000 USD
CY2020Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-2092000 USD
CY2019Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3154000 USD
CY2020Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
10749000 USD
CY2019Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-479000 USD
CY2020Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2411000 USD
CY2019Q2 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-246000 USD
CY2020Q2 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
5936000 USD
CY2019Q2 us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2020Q2 us-gaap Interest Paid Net
InterestPaidNet
67000 USD
CY2019Q2 us-gaap Inventory Net
InventoryNet
58963000 USD
CY2020Q1 us-gaap Inventory Net
InventoryNet
56901000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
67650000 USD
CY2019Q2 us-gaap Lease Cost
LeaseCost
19752000 USD
CY2020Q2 us-gaap Lease Cost
LeaseCost
19756000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
320716000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
75088000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
49542000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
34732000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
45400000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
54508000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
61446000 USD
CY2020Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
591000 USD
CY2019Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
9105000 USD
CY2020Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
11761000 USD
CY2020Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
10719000 USD
CY2019Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5209000 USD
CY2020Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5024000 USD
CY2019Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
0 USD
CY2020Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
29677000 USD
CY2020Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
0 USD
CY2019Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.306
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.379
CY2019Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7019000 USD
CY2020Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7190000 USD
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5098000 USD
CY2020Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
4900000 USD
CY2020Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y10M30D
CY2019Q2 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-10000 USD
CY2020Q2 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 USD
CY2019Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
549000 USD
CY2020Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
330000 USD
CY2019Q2 us-gaap Gross Profit
GrossProfit
35684000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
1594000 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
975000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-27992000 USD
CY2020Q2 us-gaap Debt Instrument Covenant Description
DebtInstrumentCovenantDescription
We are required to maintain certain financial and non-financial covenants in accordance with the line of credit. The financial covenants require certain levels of leverage and profitability, such as (i) income before income taxes not to be less than $1.0 million (calculated at the end of each fiscal quarter on a trailing 12-month basis), (ii) a maximum ratio of 4.00 to 1.00 as of each quarter end for “Funded Debt to EBITDAR”, defined as the sum of total debt, capital leases and annual rent expense multiplied by six divided by the sum of net income, interest expense, taxes, depreciation, amortization and annual rent expense on a trailing 12-month basis, and (iii) requires minimum eligible inventory, cash, cash equivalents and marketable securities totaling $50.0 million as of the end of each quarter. In addition, maximum investment in fixed assets in any fiscal year of $50.0 million.
CY2020Q2 us-gaap Debt Instrument Interest Rate Terms
DebtInstrumentInterestRateTerms
The interest rate charged on borrowings is selected at our discretion at the time of draw between the London Interbank Offered Rate, plus 0.75%, or at the Bank’s prime rate.
CY2019Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-130000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
298000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
300000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-10597000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-10600000 USD
CY2020Q2 us-gaap Income Tax Receivable
IncomeTaxReceivable
7200000 USD
CY2019Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
11000 USD
CY2020Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-42000 USD
CY2019Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-895000 USD
CY2020Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4661000 USD
CY2019Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-806000 USD
CY2020Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-5284000 USD
CY2020Q2 us-gaap Liabilities
Liabilities
373200000 USD
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
497285000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
36649000 USD
CY2020Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P10Y
CY2019Q2 us-gaap Liabilities
Liabilities
332755000 USD
CY2020Q1 us-gaap Liabilities
Liabilities
386739000 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
546640000 USD
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
516194000 USD
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
109247000 USD
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
145266000 USD
CY2020Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 USD
CY2020Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
23675000 USD
CY2019Q2 us-gaap Marketable Securities
MarketableSecurities
75738000 USD
CY2020Q1 us-gaap Marketable Securities
MarketableSecurities
69487000 USD
CY2020Q2 us-gaap Marketable Securities
MarketableSecurities
45706000 USD
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
143515000 USD
CY2019Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
75953000 USD
CY2014Q1 us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2023-01-31
CY2014Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
25000000 USD
CY2019Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 USD
CY2020Q2 us-gaap Line Of Credit
LineOfCredit
0 USD
CY2020Q1 us-gaap Line Of Credit
LineOfCredit
23700000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-13000 USD
CY2019Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1422000 USD
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
718000 USD
CY2020Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
69780000 USD
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
558000 USD
CY2020Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
45981000 USD
CY2019Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-29387000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6002000 USD
CY2019Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2631000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
20564000 USD
CY2019Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2278000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19566000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
677000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-17395000 USD
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
829000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
409000 USD
CY2019Q2 us-gaap Payments Of Dividends
PaymentsOfDividends
29453000 USD
CY2020Q2 us-gaap Number Of Stores
NumberOfStores
239 store
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
146000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-28401000 USD
CY2019Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
15844000 USD
CY2020Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
15915000 USD
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
284067000 USD
CY2020Q2 us-gaap Payments Of Dividends
PaymentsOfDividends
29677000 USD
CY2019Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
85000 USD
CY2019Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
52600000 USD
CY2020Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
55321000 USD
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
65595000 USD
CY2019Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
222086000 USD
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
240755000 USD
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
229127000 USD
CY2020Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
5615000 USD
CY2019Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
244139000 USD
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
263649000 USD
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
252554000 USD
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0401
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y0M0D
CY2019Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2176000 USD
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7951000 USD
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7422000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-69000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-13000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-69000 USD
CY2019Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 USD
CY2019Q2 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
34572000 USD
CY2020Q2 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
5996000 USD
CY2019Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3059000 USD
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3548000 USD
CY2019Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2019Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q2 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
66176000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
61941000 USD
CY2019Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
6288000 USD
CY2020Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
7485000 USD
CY2019Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5294000 USD
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4561000 USD
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2092000 USD
CY2020Q2 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
23675000 USD
CY2019Q2 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
35000000 USD
CY2020Q2 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
30108000 USD
CY2019Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
151000 USD
CY2020Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
70608000 USD
CY2019Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
35538000 USD
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.024
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
29995000 USD
CY2019Q2 us-gaap Share Based Compensation
ShareBasedCompensation
529000 USD
CY2020Q2 us-gaap Share Based Compensation
ShareBasedCompensation
501000 USD
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2020Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
13421000 USD
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.532
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.573
CY2020Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1896 USD
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
14012000 USD
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
6280000 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11115000 USD
CY2019Q2 us-gaap Revenues
Revenues
130303000 USD
CY2020Q2 us-gaap Revenues
Revenues
77289000 USD
CY2019Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
281000 USD
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.004
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1247443 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
9.04
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
2813 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
3000 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
616900 shares
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.50
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.05
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
892000 USD
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1993187 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2604274 shares
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.50
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.22
CY2020Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
11.33
CY2020Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
11.41
CY2020Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.12
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2019Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y4M
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 USD
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y8M20D
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y7M18D
CY2019Q2 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
8000 shares
CY2019Q2 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
26000 shares
CY2019Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
18000 shares
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
151000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
163327000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
164530000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
159901000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
142994000 USD
CY2019Q2 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
1700000 USD
CY2020Q1 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
1400000 USD
CY2020Q2 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
1700000 USD
CY2019Q2 us-gaap Variable Lease Cost
VariableLeaseCost
3908000 USD
CY2020Q2 us-gaap Variable Lease Cost
VariableLeaseCost
3841000 USD
CY2019Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
339000 shares
CY2020Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29808000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29677000 shares
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29469000 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29677000 shares
CY2020Q2 us-gaap Fiscal Period
FiscalPeriod
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our fiscal year ends on the Saturday closest to January&#160;31. References to fiscal 2020 refer to the fiscal year ending January 30, 2021. References to the fiscal quarters or three months ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;2, 2020</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">May&#160;4, 2019</font><font style="font-family:inherit;font-size:10pt;"> refer to the </font><font style="font-family:inherit;font-size:10pt;">thirteen week period ended</font><font style="font-family:inherit;font-size:10pt;"> as of those dates, respectively.</font></div></div>

Files In Submission

Name View Source Status
0001628280-20-009439-index-headers.html Edgar Link pending
0001628280-20-009439-index.html Edgar Link pending
0001628280-20-009439.txt Edgar Link pending
0001628280-20-009439-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
q1202010-q.htm Edgar Link pending
q12020ex311.htm Edgar Link pending
q12020ex312.htm Edgar Link pending
q12020ex321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tlys-20200502.xml Edgar Link completed
tlys-20200502.xsd Edgar Link pending
tlys-20200502_cal.xml Edgar Link unprocessable
tlys-20200502_def.xml Edgar Link unprocessable
tlys-20200502_lab.xml Edgar Link unprocessable
tlys-20200502_pre.xml Edgar Link unprocessable